Protara Therapeutics, Inc. Shares Outstanding (Cover Page)
Protara Therapeutics, Inc. (TARA) had Shares Outstanding (Cover Page) of 59.10 million shares as of 2026-08-07, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-07: Entity Common Stock, Shares Outstanding 59.10M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 56.20M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 54.08M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 38.59M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 59.10M shares 10-Q · filed 2026-08-11 |
| 2026-05-08 | 56.20M shares 10-Q · filed 2026-05-13 |
| 2026-03-05 | 54.08M shares 10-K · filed 2026-03-10 |
| 2025-11-06 | 38.59M shares 10-Q · filed 2025-11-10 |
| 2025-08-06 | 38.58M shares 10-Q · filed 2025-08-11 |
| 2025-05-01 | 38.58M shares 10-Q · filed 2025-05-08 |
| 2025-02-28 | 36.77M shares 10-K · filed 2025-03-05 |
| 2024-11-07 | 20.63M shares 10-Q · filed 2024-11-12 |
| 2024-08-01 | 20.63M shares 10-Q · filed 2024-08-06 |
| 2024-04-30 | 20.59M shares 10-Q · filed 2024-05-02 |
| 2024-03-08 | 11.43M shares 10-K · filed 2024-03-13 |
| 2023-11-01 | 11.36M shares 10-Q · filed 2023-11-03 |
| 2023-08-01 | 11.33M shares 10-Q · filed 2023-08-03 |
| 2023-05-01 | 11.31M shares 10-Q · filed 2023-05-04 |
| 2023-03-03 | 11.31M shares 10-K · filed 2023-03-08 |
| 2022-10-31 | 11.27M shares 10-Q · filed 2022-11-03 |
| 2022-08-05 | 11.27M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 11.25M shares 10-Q · filed 2022-05-05 |
| 2022-03-04 | 11.25M shares 10-K · filed 2022-03-09 |
| 2021-11-03 | 11.24M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 11.24M shares 10-Q · filed 2021-08-05 |
| 2021-05-05 | 11.23M shares 10-Q · filed 2021-05-06 |
| 2021-03-09 | 11.23M shares 10-K · filed 2021-03-11 |
| 2020-11-10 | 11.21M shares 10-Q · filed 2020-11-12 |
| 2020-07-31 | 5.86M shares 10-Q · filed 2020-07-31 |
| 2020-05-12 | 5.84M shares 10-Q · filed 2020-05-13 |
| 2020-03-19 | 5.84M shares 10-K · filed 2020-03-20 |
| 2019-10-28 | 19.59M shares 10-Q · filed 2019-10-31 |
| 2019-08-05 | 19.59M shares 10-Q · filed 2019-08-07 |
| 2019-05-06 | 19.59M shares 10-Q · filed 2019-05-08 |
| 2019-03-08 | 19.24M shares 10-K · filed 2019-03-13 |
| 2018-11-02 | 19.22M shares 10-Q · filed 2018-11-07 |
| 2018-07-31 | 17.73M shares 10-Q · filed 2018-08-07 |
| 2018-04-30 | 17.67M shares 10-Q · filed 2018-05-09 |
| 2018-03-09 | 17.67M shares 10-K · filed 2018-03-14 |
| 2017-10-31 | 17.62M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 17.62M shares 10-Q · filed 2017-08-07 |
| 2017-04-30 | 16.77M shares 10-Q · filed 2017-05-10 |
| 2017-03-10 | 16.60M shares 10-K · filed 2017-03-16 |
| 2016-10-31 | 16.59M shares 10-Q · filed 2016-11-07 |
| 2016-07-31 | 16.58M shares 10-Q · filed 2016-08-08 |
| 2016-04-30 | 16.57M shares 10-Q · filed 2016-05-09 |
| 2016-03-10 | 16.51M shares 10-K · filed 2016-03-14 |
| 2015-10-31 | 16.48M shares 10-Q · filed 2015-11-12 |
| 2015-07-31 | 16.46M shares 10-Q · filed 2015-08-13 |
| 2015-04-30 | 16.45M shares 10-Q · filed 2015-05-13 |
| 2015-03-16 | 16.45M shares 10-K · filed 2015-03-20 |
| 2014-11-24 | 16.45M shares 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |